Phytonadione (Phytonadione (Vit K1)) Patent Expiration, LOE Window & CMS Spending

Phytonadione (Phytonadione (Vit K1)) by Zydus Pharmaceu: Off-Patent Genericized (AB Competition), 0 AB generics, $5.9M 2024 CMS Part D & Medicaid spend, and $1,069 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorZydus Pharmaceu
FDA Application & PathwayReconciled (UNLINKED)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$5.9M
2024 Medicare Part D Spend$26K
2024 Medicaid Spend$5.8M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,069 intro WAC)